Anavex Life Sciences Corp. (Nasdaq: AVXL) announced that stockholders voted to elect all six director nominees at the company's 2026 Annual Meeting of Stockholders, based on preliminary vote counts provided by its proxy solicitor.

The six elected directors are Dr. Jiong Ma, Dr. Peter Donhauser, Dr. Axel Paeger, Mr. Gautam Patel, Dr. Adrian Senderowicz, and Dr. Claus van der Velden.

Dr. Jiong Ma, Independent Chair of the Board, said, "On behalf of the new Anavex Board of Directors, I would like to thank our stockholders for their trust and support during a pivotal time for our business. Today's outcome reflects confidence in the Board and management team's ability to execute on our refocused strategy."

Following the constitution of the newly elected board, Anavex said it intends to refresh its committee memberships and will disclose the new committee assignments after final voting results are filed.

The results announced are preliminary and subject to change until tabulated and certified by the independent inspector of election. Anavex will report the final voting results in a Form 8-K filing with the U.S. Securities and Exchange Commission.